Objective To investigate the effect of Saikosaponin A(SSA)on the differentiation,apoptosis and function of mouse bone marrow derived macrophages(BMDM)-derived M1/M2 macrophages,and to explore its molecular mechanism.Methods BMDM was induced to differentiate into M1/M2 macrophages in vitro,and SSA was added at the same time:CCK-8 assay was used to detect the viability of BMDM and M1/M2 macrophages.The morphology of M1/M2 macrophages was observed by inverted fluorescence microscopy.Flow cytometry(FCM)and ELISA were used to detect the levels of surface markers and cytokines in M1/M2 macrophages.Real-time fluorescent quantitative PCR(qPCR)was used to detect the mRNA levels of IL-6,TNF-α and arginase-1(Arg-1).FCM was used to detect the phagocytosis of peritoneal macrophages to fluorescent microsphere particles.Immunofluorescence(IF)assay and Western blotting were used to detect the molecular mechanism of SSA regulating M1/M2 macrophages.Results No significant effect on viability of M1/M2 macrophages was observed at SSA concentration of 10.0 mg/L,and obvious inhibition was seen at a concentration of 15.0 mg/L(P<0.01).Treatment of 10.0 mg/L SSA induced obvious morphologic changes in M1/M2 macrophages,with M1 macrophages in irregular shape,a few having pseudopods,and some showing unclear boundaries;while some M2 macrophages presenting round or irregular(P<0.001)with unclear boundaries.SSA treatment also resulted in significantly decreased proportion of M1/M2 macrophages after BMDM differentiation(P<0.05),with reduced contents of IL-6 and TNF-α secreted by M1 macrophages and their mRNA levels(P<0.05),but increased secretion of Arg-1 and mRNA levels by M2 macrophages(P<0.05).SSA treatment also inhibited the phagocytosis ability of peritoneal macrophages to fluorescent microsphere particles(P<0.01)in a concentration-dependent manner.SSA decreased the phosphorylation of NF-kappaB(p-NF-κB)(P<0.01)and enhanced the phosphorylation of signal transducer and activator of transcription 6(p-STAT6)in M2 macrophages(P<0.05).Conclusion SSA may affect the differentiation and function of M1/M2 macrophages by regulating NF-κB and STAT6 signaling pathways.

Objective·To study the regulatory effect of saikosaponin A(SSA)on the differentiation,apoptosis,and immunosuppressive function of myeloid-derived suppressor cells(MDSCs)in mice,and to explore their molecular mechanism.Methods·Recombinant mouse granulocyte-macrophage colony-stimulating factor(GM-CSF)was used to induce the differentiation of mouse bone marrow cells(BMCs)into MDSCs,or magnetic beads were used to sort MDSCs from tumor-bearing mice.After treating MDSCs with different concentrations(0,2.5,5.0 mg/L),flow cytometry(FCM)was used to detect the differentiation and apoptosis of MDSCs,as well as the expression levels of liver X receptor α(LXRα),arginase-1(Arg-1),and reactive oxygen species(ROS).At the same time,the effects of MDSCs on the proliferation function of T cells,and the effects on the nuclear factor κB(NF-κB),and signal transducer and activator of transcription 1(STAT1)signaling pathways were also detected.The mRNA levels of LXRα and Arg-1 were detected by quantitative real-time PCR(qPCR).Mice were given SSA by gavage(ig)or intraperitoneal injection(ip),and the mice were sacrificed after administration;and body mass,spleen weight,and spleen index were calculated.FCM was used to detect the proportion of immune cells in the spleen of mice.Results·SSA could up-regulate the expression level of LXRα in MDSCs,reduce the differentiation of M-MDSCs,induce apoptosis of MDSCs,reduce the expression levels of Arg-1 and ROS in MDSCs,and reduce the inhibitory effect of MDSCs on T cell proliferation.SSA inhibited the phosphorylation levels of NF-κB and STAT1 in MDSCs.The mice treated with SSA by gavage or intraperitoneal injection showed no significant changes in body weight and spleen index.Both modes of administration can reduce the proportion of MDSCs and their subset M-MDSCs in mice,but had different degrees of regulatory effects on other immune cells.Conclusion·SSA could regulate the differentiation and apoptosis of MDSCs,and inhibit their immunosuppressive function,which may be associated with the up-regulation of LXRα expression,and down-regulation of the NF-κB and STAT1 signaling pathways in MDSCs.

Objective·To study the regulatory effect of saikosaponin A(SSA)on the differentiation,apoptosis,and immunosuppressive function of myeloid-derived suppressor cells(MDSCs)in mice,and to explore their molecular mechanism.Methods·Recombinant mouse granulocyte-macrophage colony-stimulating factor(GM-CSF)was used to induce the differentiation of mouse bone marrow cells(BMCs)into MDSCs,or magnetic beads were used to sort MDSCs from tumor-bearing mice.After treating MDSCs with different concentrations(0,2.5,5.0 mg/L),flow cytometry(FCM)was used to detect the differentiation and apoptosis of MDSCs,as well as the expression levels of liver X receptor α(LXRα),arginase-1(Arg-1),and reactive oxygen species(ROS).At the same time,the effects of MDSCs on the proliferation function of T cells,and the effects on the nuclear factor κB(NF-κB),and signal transducer and activator of transcription 1(STAT1)signaling pathways were also detected.The mRNA levels of LXRα and Arg-1 were detected by quantitative real-time PCR(qPCR).Mice were given SSA by gavage(ig)or intraperitoneal injection(ip),and the mice were sacrificed after administration;and body mass,spleen weight,and spleen index were calculated.FCM was used to detect the proportion of immune cells in the spleen of mice.Results·SSA could up-regulate the expression level of LXRα in MDSCs,reduce the differentiation of M-MDSCs,induce apoptosis of MDSCs,reduce the expression levels of Arg-1 and ROS in MDSCs,and reduce the inhibitory effect of MDSCs on T cell proliferation.SSA inhibited the phosphorylation levels of NF-κB and STAT1 in MDSCs.The mice treated with SSA by gavage or intraperitoneal injection showed no significant changes in body weight and spleen index.Both modes of administration can reduce the proportion of MDSCs and their subset M-MDSCs in mice,but had different degrees of regulatory effects on other immune cells.Conclusion·SSA could regulate the differentiation and apoptosis of MDSCs,and inhibit their immunosuppressive function,which may be associated with the up-regulation of LXRα expression,and down-regulation of the NF-κB and STAT1 signaling pathways in MDSCs.

Myeloid-derived suppressor cells (MDSCs) are a heterogeneous cell population of myeloid origin with immunosuppressive function. MDSCs can inhibit the normal immune response of the host to tumor by inhibiting the activity of T cells, natural killer cells, macrophage, B cells, and promoting the proliferation of Treg and other mechanisms. Therefore, MDSCs are potential targets for tumor immunotherapy. However, whether immunotherapy or other treatments, the effectiveness of monotherapy is limited, so immunotherapy combined with other treatments is a breakthrough combination. In recent years, immunotherapy combined with other treatments has shown initial results, with better results than monotherapy. It has become a research hotspot in tumor treatment and a new treatment method in the future. This article summarized the research progress on the effects of immunotherapy combined with chemotherapy, radiotherapy, Chinese herbal extract and Immunotherapy combination on MDSCs, in order to provide theoretical support for the clinical application of immunotherapy based combined tumor treatment measures.

Objective To investigate the effect of Angelica polysaccharide(APS)on the differentiation and function of M2 macrophages and underlying molecular mechanism.Methods Mouse bone marrow derived macrophages(BMDM)and M2 macrophages were induced and treated with APS(0,80,160,320 μg/mL);Mouse peritoneal macrophages were isolated and treated with APS(0,160 μg/mL).Flow cytometry(FCM)was used to detect mannose receptor(MR),CD11b,F4/80,CD163,and ARG-1 expression levels,apoptosis,and phagocytic ability of M2 macrophages and peritoneal macrophages.Mice were randomly divided into APS gavage group and control group,APS was intragastrically administered to mice,and macrophage MR expression level in blood and spleen were detected by FCM.Fluorescence microscopy was used to observe the morphology of BMDM-differentiated M2 macrophages.RT-qPCR was employed to detect the mRNA expression levels of MR and ARG-1 in M2 macrophages.Immunofluorescence assay was performed to detect the expression of the proteins related to molecular mechanism of differentiation and function of M2 macrophages.Results Compared with the 0 μg/mL APS group,the MR expression level in the M2 macrophages was decreased with the increase of APS concentration within a certain concentration range(80～320 μg/mL),and the MR expression level in peritoneal macrophages was also decreased in the 160 μg/mL APS treatment group(P＜0.01).The expression level of macrophage MR was also significantly decreased in peripheral blood and spleen in the APS gavage mice than the control group(P＜0.05).Compared with the 0 μg/mL APS group,the expression levels of CD11b,F4/80,and CD163 in the macrophages were increased in the 80～320 μg/mL APS treatment groups(P＜0.01).The morphology of macrophage had changed,from mostly spindle-shaped and pseudopodia to mostly round or irregular,and even a few cells with pseudopodia.APS induced apoptosis in M2 macrophages(P＜0.05).Compared with the 0 μg/mL APS group,M2 macrophages treated with 160 μg/mL APS had an increased ability to phagocytose fluorescent microspheres(P＜0.01),but the expression level of ARG-1 was decreased(P＜0.01).The mRNA expression of MR and ARG-1 in M2 macrophages was decreased(P＜0.05).The mean fluorescence intensity of phosphate acidified-signal transducers and activators of transcription 6(p-STAT6)-positive signals in M2 macrophages was significantly reduced in the 160 μg/mL APS-treated group(P＜0.05).Conclusion APS has bidirectional regulation on the differentiation and function of M2 macrophages,which may be associated with its downregulation of signal transducers and activators of transcription 6(STAT6)signaling pathway.

The sternum is the pivotal component of the thoracic cavity. It is connected with the clavicle and ribs on the upper part and both sides respectively, and plays an important role in protecting the stability of the chest wall. Sternal resection usually results in a large segmental chest wall defect that causes the chest wall to float and requires sternal reconstruction. This paper reports a 62 years male patient with thymic squamous cell carcinoma with sternal metastasis, who underwent thymotomy, sternal tumor resection and autologous lilum graft combined with sternal reconstruction by titanium plate after relevant examination was completed and surgical contraindications were eliminated. The patient was followed up for 6 months, the respiratory and motor functions were normal and the thoracic appearance was good.

As a novel and promising antitumor target, AXL plays an important role in tumor growth, metastasis, immunosuppression and drug resistance of various malignancies, which has attracted extensive research interest in recent years. In this study, by employing the structure-based drug design and bioisosterism strategies, we designed and synthesized in total 54 novel AXL inhibitors featuring a fused-pyrazolone carboxamide scaffold, of which up to 20 compounds exhibited excellent AXL kinase and BaF3/TEL-AXL cell viability inhibitions. Notably, compound 59 showed a desirable AXL kinase inhibitory activity (IC₅₀: 3.5 nmol/L) as well as good kinase selectivity, and it effectively blocked the cellular AXL signaling. In turn, compound 59 could potently inhibit BaF3/TEL-AXL cell viability (IC₅₀: 1.5 nmol/L) and significantly suppress GAS6/AXL-mediated cancer cell invasion, migration and wound healing at the nanomolar level. More importantly, compound 59 oral administration showed good pharmacokinetic profile and in vivo antitumor efficiency, in which we observed significant AXL phosphorylation suppression, and its antitumor efficacy at 20 mg/kg (qd) was comparable to that of BGB324 at 50 mg/kg (bid), the most advanced AXL inhibitor. Taken together, this work provided a valuable lead compound as a potential AXL inhibitor for the further antitumor drug development.

Myeloid-derived suppressor cells (MDSCs) play an important immunosuppressive role in the tumor microenvironment. Tumor cells can regulate the immunosuppressive function of MDSCs in the tumor microenvironment through exosomes, thereby affecting the development of tumors. Tumor-derived exosomes (TEXs) promote the development of MDSCs and improve their immunosuppressive function in the tumor microenvironment mainly by participating in the processes such as intercellular information exchange and information transmission. Moreover, the miRNAs in TEXs will also be transferred to recipient cells to inhibit the immunosuppressive function of MDSCs by inducing the negative regulation of target genes. This review summarized the progress in the mechanism of TEXs on MDSCs.

Fibroblast growth factor receptors (FGFRs) have emerged as promising targets for anticancer therapy. In this study, we synthesized and evaluated the biological activity of 66 pyrazolo[3,4-

Parkinson's disease (PD) is the second most common neurodegenerative disease, but none of the current treatments for PD can halt the progress of the disease due to the limited understanding of the pathogenesis. In PD development, the communication between the brain and the gastrointestinal system influenced by gut microbiota is known as microbiota-gut-brain axis. However, the explicit mechanisms of microbiota dysbiosis in PD development have not been well elucidated yet. FLZ, a novel squamosamide derivative, has been proved to be effective in many PD models and is undergoing the phase I clinical trial to treat PD in China. Moreover, our previous pharmacokinetic study revealed that gut microbiota could regulate the absorption of FLZ